Tuberculin skin testing
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Tuberculin skin testing
  • Published Date:

    October 2011

  • Source:
    TB elimination
  • Language:
    English
Filetype[PDF-195.72 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 322.09 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    October 2011
    Source:
    TB elimination
    Description:
    BCG, or bacille Calmette-Guérin, is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary dise...
    File Type:
    Filetype[PDF - 322.09 KB]
  2. Filetype[PDF - 62.70 KB]
    Published Date:
    June 21 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(24):552-553
    Description:
    CDC is expecting a 3-10 month nationwide shortage of Aplisol, a product of Par Pharmaceuticals, and one of two purified-protein derivative (PPD) tuberculin antigens licensed by the Food and Drug Administration (FDA) for use in performing tuberculin s...
    File Type:
    Filetype[PDF - 62.70 KB]
  3. Filetype[PDF - 193.01 KB]
    Personal Author:
    Styrt, Barbara A.; Villarino, Margarita E.;
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    September 5, 1997
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 46, no. RR-15
    Description:
    This report updates and supersedes previous recommendations (MMWR 1991;40[No. RR-5]:27-33) for the use of anergy skin testing in conjunction with purified protein derivative (PPD)-tuberculin skin testing of persons infected with human immunodeficienc...
    File Type:
    Filetype[PDF - 193.01 KB]
  4. Filetype[PDF - 1.40 MB]
    Personal Author:
    Thompson, D. H.; Greenberg, H. B.;
    Published Date:
    Apr 1971
    Source:
    HSMHA Health Rep. 86(4):381-384
    Description:
    Images
    File Type:
    Filetype[PDF - 1.40 MB]
  5. Filetype[PDF - 389.84 KB]
    Personal Author:
    Bailey, W C; Thompson, D H; Greenberg, H B;
    Published Date:
    1974 Sep-Oct
    Source:
    Public Health Rep. 89(5):465-467
    File Type:
    Filetype[PDF - 389.84 KB]